Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,662.00
(
0.21%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: Biowatch post# 35250

Tuesday, 10/10/2006 5:57:14 PM

Tuesday, October 10, 2006 5:57:14 PM

Post# of 257267
I would guess Macugen sales were hurt the most. A lot of retinal specialists are still using visudyne in combo with avastin or Lucentis. Lucentis uses the same MOA as Macugen but works 100x better. I think visudyne might stick around for a while but macugen is over.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today